SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Raymed Labs informs about closure of trading window

28 Jan 2017 Evaluate

Raymed Labs has informed that the Meeting of the Board of Directors of the Company will be held on February 10, 2017, to consider and approve the Unaudited Standalone Financial Results for the quarter and period ended on December 31, 2016, and Limited Review Report for the quarter and period ended December 31, 2016. Pursuant to the code of conduct for prevention of insider trading of the company, the trading window for all designated employees & directors will remain closed from January 28, 2017 to February 12, 2017 which is till 48 hours after results are made public on February 10, 2017.

The above information is a part of company’s filings submitted to BSE.

Cresanto Global Share Price

4.65 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1867.80
Dr. Reddys Lab 1301.30
Cipla 1433.10
Zydus Lifesciences 1112.10
Lupin 2356.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: